Journal of Business Chemistry October 2016

The landscape of the chemical, pharmaceutical and biotech industry has changed over the past years, not least due to mergers and acquisitions. Most prominent examples are Bayer’s latest acquisition of Monsanto and the rumors about Dow and DuPont merging their businesses. Among the companies, which are not involved in M&A negotiations recently, the tendency to […]

Abstract The chemical industry is one of the major global industries with specific management challenges. It is an industry in transition. Compared with its economic importance and its role in providing solutions for grand societal challenges, this industry as well as companies from pharmaceutical and biotech sectors receive comparatively little attention from management literature. With […]

Since 2008 Hariolf Kottmann, holding a PhD in organic chemistry, is Chief Executive Officer of the Swiss specialty chemical company Clariant. The corporation is headquartered in Basel and is operating in 53 countries worldwide. In 2015, Clariant occupied 17,213 employees of which around 1,100 (6.4%) are working in R&D. By focusing on the four business areas care chemicals, […]

Abstract Recent success of advanced computational chemistry, in example for the prediction of chemical reactivity and materials properties, reflects its reputation as a valuable and widely accepted means to tackle problems in academia. The development of new simulation methods and new computer architectures enables an enormous improvement of the productivity of research and development of […]